Blog and Topics

Exhibition Report : INTERPHEX Week TOKYO2025 / Regenerative Medicine EXPO

From July 9th to 11th, 2025, Teijin Regenet and J-TEC jointly exhibited at INTERPHEX Week Tokyo 2025 Regenerative Medicine EXPO, attracting many visitors. Thank you very much for taking the time to visit us despite the summer heat!

▼Number of Visitors to INTERPHEX*

*Excerpted from the official INTERPHEX website.

▼Booth Scene During the Exhibition Period

At the booth, we mainly introduced the following about Teijin Regenet :

●Teijin Regenet Listed in METI's “CDMO Company List for Regenerative Medicine Products”.

-What is the CDMO Company List for Regenerative Medicine Products?

The list was created by Japan’s Ministry of Economy, Trade and Industry (METI) in collaboration with the Forum for Innovative Regenerative Medicine (FIRM) to promote infrastructure development and industrialization in the biopharmaceutical manufacturing  field by visualizing the experiences and achievements of domestic CDMO companies.
The list includes detailed information on the services provided by Teijin Regenet, its facilities and equipment, partner companies, and overall corporate strengths.

Teijin Regenet continues to leverage its reliable technology and experience in the field of regenerative medicine to meet medical needs both domestically and internationally.
Being listed in this report is part of our ongoing efforts and symbolizes future growth and advancement.

●Strategic Business Alliance Between Teijin and Hillman Laboratories for Regenerative Medicine CDMO.

Teijin and Hillman Laboratories, a biotechnology company based in Singapore, have entered into a strategic international business alliance concerning CDMO services in the regenerative medicine field.

Going forward, both companies will build a strong collaborative framework to offer valuable development and manufacturing support services across the Asia-Pacific region.

●Teijin Regenet, Toho Holdings, and ITOCHU Corporation Form Business Alliance for a “Regenerative Medicine Ecosystem”.

-Leading industry players collaborate to accelerate the commercialization of promising regenerative medicine seeds.

Teijin Regenet, Toho Holdings and ITOCHU Corporation have signed a business alliance agreement aimed at building a “Regenerative Medicine Ecosystem” to support biotech ventures engaged in the development of regenerative medicine products.

By combining the unique strengths of each company across different fields, this one-stop development support service aims to create an environment that allows biotech startups to efficiently and swiftly bring their products to market.

 

Teijin Regenet will continue to provide comprehensive CDMO services tailored to clients, from research and development of regenerative medicine products, to business planning and commercial manufacturing.

If you have any questions or inquiries, please feel free to contact us.